BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10086071)

  • 1. Characterization of human chorionic gonadotropin peptide variants with a radio-receptor assay using recombinant human luteinizing hormone/chorionic gonadotropin receptors.
    Ho HH; O'Connor JF; Overstreet JW; Lasley BL
    Early Pregnancy; 1997 Sep; 3(3):204-12. PubMed ID: 10086071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
    Sonoda N; Katabuchi H; Tashiro H; Ohba T; Nishimura R; Minegishi T; Okamura H
    Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deglycosylated human chorionic gonadotropin (hCG) antagonizes hCG stimulation of 3',5'-cyclic adenosine monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing hormone receptors.
    Dunkel L; Jia XC; Nishimori K; Boime I; Hsueh AJ
    Endocrinology; 1993 Feb; 132(2):763-9. PubMed ID: 8381073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG).
    Morbeck DE; Roche PC; Keutmann HT; McCormick DJ
    Mol Cell Endocrinol; 1993 Nov; 97(1-2):173-81. PubMed ID: 8143901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteinizing hormone and human chorionic gonadotropin: origins of difference.
    Choi J; Smitz J
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):203-13. PubMed ID: 24365330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the glycan moiety of the rat ovarian luteinizing hormone/chorionic gonadotropin (CG) receptor and human CG for receptor-hormone interaction.
    Petäjä-Repo UE; Merz WE; Rajaniemi HJ
    Endocrinology; 1991 Mar; 128(3):1209-17. PubMed ID: 1999142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human chorionic gonadotropin in normal and abnormal pregnancies.
    Ho HH; O'Connor JF; Nakajima ST; Tieu J; Overstreet JW; Lasley BL
    Early Pregnancy; 1997 Sep; 3(3):213-24. PubMed ID: 10086072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone/chorionic gonadotropin bioactivity in the common marmoset (Callithrix jacchus) is due to a chorionic gonadotropin molecule with a structure intermediate between human chorionic gonadotropin and human luteinizing hormone.
    Simula AP; Amato F; Faast R; Lopata A; Berka J; Norman RJ
    Biol Reprod; 1995 Aug; 53(2):380-9. PubMed ID: 7492691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species.
    Jia XC; Oikawa M; Bo M; Tanaka T; Ny T; Boime I; Hsueh AJ
    Mol Endocrinol; 1991 Jun; 5(6):759-68. PubMed ID: 1922095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional determinant in human luteinizing hormone and chorionic gonadotropin: differential effect of mutations about beta-GLN-54.
    Hu SB; Johnson L; Roche PC; Keutmann HT
    Endocrinology; 1997 Apr; 138(4):1627-33. PubMed ID: 9075724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: biological and diagnostic relevance.
    Lottersberger C; Hoermann R; Mann K; Schwarz S; Berger P
    Horm Res; 2003; 59(3):125-34. PubMed ID: 12637792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling.
    Lazzaretti C; Secco V; Paradiso E; Sperduti S; Rutz C; Kreuchwig A; Krause G; Simoni M; Casarini L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of complimentarity between monoclonal antibodies (MAbs) to human chorionic gonadotropin (hCG) and polyclonal antibodies to luteinizing hormone/hCG receptor (LH-R) and their use in better understanding hormone-receptor interaction.
    Jeyakumar M; Krishnamurthy HN; Dighe RR; Moudgal NR
    Recept Signal Transduct; 1997; 7(4):299-310. PubMed ID: 9633830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
    Schubert RL; Narayan P; Puett D
    Endocrinology; 2003 Jan; 144(1):129-37. PubMed ID: 12488338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction, signal generation, signal divergence, and signal transduction of LH/CG and the receptor.
    Ji TH; Ryu KS; Gilchrist R; Ji I
    Recent Prog Horm Res; 1997; 52():431-53; discussion 454. PubMed ID: 9238862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a fluorescence based high throughput assay for antagonists of the human chorionic gonadotropin receptor extracellular domain: analysis of peptide inhibitors.
    Lobel LI; Morseman JP; Zeng X; Lustbader JW; Chen H; Allnutt FC
    J Biomol Screen; 2001 Jun; 6(3):151-8. PubMed ID: 11689111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the receptor binding regions of human chorionic gonadotropin (hCG) using disulfide peptides of its beta-subunit: possible involvement of the disulfide bonds Cys(9)-Cys(57) and Cys(23)-Cys(72) in receptor binding of the hormone.
    Mishra AK; Mahale SD; Iyer KS
    J Pept Res; 2001 Jul; 58(1):17-26. PubMed ID: 11454166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.
    Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S
    Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite contribution of two ligand-selective determinants in the N-terminal hormone-binding exodomain of human gonadotropin receptors.
    Vischer HF; Granneman JC; Bogerd J
    Mol Endocrinol; 2003 Oct; 17(10):1972-81. PubMed ID: 12869592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.